As mentioned above, the SS18-SSX fusion proteins are widely considered to be the main driver of SS pathogenesis [83, 84], as their expression is sufficient to induce SS tumors in mice [6, 72], and their silencing causes SS cells to revert to mesenchymal stem cell-like cells [5]. Here, SSX2 is linked to synovial sarcoma.